Publication | Closed Access
LBA24 KRYSTAL-1: Updated efficacy and safety of adagrasib (MRTX849) with or without cetuximab in patients with advanced colorectal cancer (CRC) harboring a KRASG12C mutation
23
Citations
0
References
2022
Year
Lba24 Krystal-1Gastrointestinal OncologyMedicineImmunologyPathologyColorectal CancerImmune Checkpoint InhibitorMolecular OncologyCancer TreatmentCancer GeneticsAdvanced Colorectal CancerOncologyRadiation OncologyCancer ResearchKrasg12c Mutation
No additional data available for this publication yet. Check back later!